Indication: Pulmonary Hypertension
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation And Verification Clinical Study To Assess The Safety And Efficacy Of Pulsed, Inhaled Nitric Oxide (iNO) In Subjects At Risk Of Pulmonary
Drug Study
Principal Investigator: John McConnell, M.D.Norton Pulmonary Specialists
Sponsor: Bellerophon Pulse Technologies LLC
